As a healthcare professional, it is important to note that Ozempic (semaglutide) is not specifically indicated nor approved by the FDA for weight loss. However, some individuals may experience weight loss as a potential side effect of taking Ozempic for the treatment of type 2 diabetes. The mechanism behind this weight loss is believed to be related to the medication’s effects on appetite regulation and delaying gastric emptying. It is crucial for patients to consult with their healthcare provider before using Ozempic for weight loss purposes, as there are potential risks and side effects associated with its use. Healthcare professionals should educate patients about proper dosing, monitoring blood sugar levels, and implementing lifestyle changes such as diet and exercise in conjunction with medication therapy.